Harrow, Inc.

HROW

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001360214

SEC filings (opens in a new tab)

In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 11, 2026: $1.10B
Insider buysOpen market, last 90 days: 0
Insider sellsLast 90 days, $450.0K in total: 1
13F holdersQ2 2026, +6 vs. previous quarter: 223
13F valueReported value at the end of Q2 2026: $912.6M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $272.3M; +36.4% year over year
Net income, FY2025: -$5.14M; No comparable prior period
Free cash flow, FY2025: $43.0M; No comparable prior period
Revenue, Q3 FY2026: $99.3M; +38.6% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $5.14M (1.9% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 7.09M; Shares sold short
Change: −382.4K; −5.1% vs. previous
Days to cover: 14.13; At average daily volume

Superinvestors holding HROW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HROW at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Harrow, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 17, 2026 (view filing)5:47 PM ET	Aug 14	3 days	Shojaei AmirCHIEF SCIENTIFIC OFFICER	SSale	−11.3K	$40.00	−$450.0K	−100.0%0 after
May 19, 2026 (view filing)	May 18	1 day	Graves Adrienne LDirector	PPurchase	+1.00K	$31.07	+$31.1K	New position1.00K after
May 19, 2026 (view filing)	May 18	1 day	Silvernail Lauren PDirector	PPurchase	+1.00K	$31.00	+$31.0K	New position1.00K after
May 15, 2026 (view filing)	May 14	1 day	Baum Mark LCHIEF EXECUTIVE OFFICER	PPurchase	+10.0K	$30.20	+$302.0K	+0.3%3.00M after
May 15, 2026 (view filing)	May 14	1 day	Boll Andrew R.PRESIDENT AND CFO	PPurchase	+3.50K	$29.90	+$104.7K	+0.4%814.7K after
Mar 5, 2026 (view filing)	Mar 3-4	2 days	Opaleye Management Inc.10% Owner	SSaleCommon Stock, par value $0.001 per share	−198.6K	$39.51	−$7.85M	−77.0%59.4K after	4 lots
Mar 3, 2026 (view filing)	Feb 27	4 days	Opaleye Management Inc.10% Owner	SSaleCommon Stock, par value $0.001 per share	−5.00K	$54.18	−$270.9K	−7.1%65.0K after
Jan 8, 2026 (view filing)	Jan 6	2 days	Opaleye Management Inc.10% Owner	SSaleCommon Stock, par value $0.001 per share	−20.0K	$53.35	−$1.07M	−22.2%70.0K after
Jun 11, 2025 (view filing)	Jun 9-10	2 days	Opaleye Management Inc.10% Owner	SSaleCommon Stock, par value $0.001 per share	−30.2K	$30.58	−$923.7K	−25.1%90.0K after	2 lots
Jun 5, 2025 (view filing)	Jun 3-4	2 days	Opaleye Management Inc.10% Owner	SSaleCommon Stock, par value $0.001 per share	−4.80K	$30.03	−$144.0K	−3.8%120.2K after	2 lots

Top 10 13F holders, Q2 2026

See all 223 holders

The largest institutional positions in Harrow, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HROW in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
BlackRock, Inc.	2,740,117	$116.4M	0.00%	+187,358+7.3%	Added
Opaleye Management Inc.	2,400,000	$101.9M	9.23%	−432,230−15.3%	Reduced
Private Capital Management, LLC	1,598,770	$67.9M	6.16%	+36,770+2.4%	Added
Vanguard Capital Management LLC	1,417,212	$60.2M	0.00%	+14,156+1.0%	Added
Deep Track Capital, LP	969,000	$41.2M	0.61%	+969,000	New
State Street Corp	939,888	$39.9M	0.00%	+84,841+9.9%	Added
Geode Capital Management, LLC	905,560	$38.5M	0.00%	+53,526+6.3%	Added
Bamco Inc	809,350	$34.4M	0.05%	+809,350	New
Dimensional Fund Advisors LP	667,036	$28.3M	0.01%	+87,516+15.1%	Added
Jupiter Topco LLC	579,127	$24.6M	0.01%	+579,127	New

Holders of 5% or more of HROW

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Harrow, Inc..

Largest holders of HROW from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Baum Mark L	13D/A	10.69%4.06M shares	–	Apr 27, 20213 filings	Apr 7, 2025	SEC
BlackRock, Inc.	13G/A	7.40%2.76M shares	–	Oct 27, 20261 filing	Oct 27, 2026	SEC
Opaleye Management Inc.	13G/A	5.62%2.10M shares	−0.82 ppfrom 6.44%	Feb 12, 20217 filings	Nov 6, 2026	SEC
Kaufman Daniel Louis	13G	5.04%1.88M shares	–	Nov 24, 20234 filings	Mar 11, 2026	SEC